Northstar Group’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-3,658
Closed -$327K 135
2018
Q3
$327K Hold
3,658
0.15% 104
2018
Q2
$291K Sell
3,658
-325
-8% -$27K 0.15% 109
2018
Q1
$355K Buy
3,983
+200
+5% +$19.2K 0.18% 91
2017
Q4
$395K Buy
3,783
+1,175
+45% +$133K 0.21% 88
2017
Q3
$380K Buy
2,608
+708
+37% +$96.4K 0.22% 90
2017
Q2
$247K Sell
1,900
-100
-5% -$12.3K 0.15% 104
2017
Q1
$248K Sell
2,000
-100
-5% -$12K 0.16% 103
2016
Q4
$243K Hold
2,100
0.17% 95
2016
Q3
$220K Hold
2,100
0.16% 100
2016
Q2
$207K Hold
2,100
0.15% 94
2016
Q1
$210K Sell
2,100
-100
-5% -$10.3K 0.16% 95
2015
Q4
$263K Hold
2,200
0.21% 84
2015
Q3
$256K Hold
2,200
0.21% 87
2015
Q2
$255K Hold
2,200
0.19% 93
2015
Q1
$254K Hold
2,200
0.2% 95
2014
Q4
$246K Buy
+2,200
New +$232K 0.19% 95

Other funds holding CELG

Northstar Group's CELG Position: Q4 2018 in Review

Northstar Group sold out of Celgene Corp (CELG) in Q4 2018, closing a stake of 3,658 shares — an estimated $327K sold.

Northstar Group first reported a position in CELG in Q4 2014 and held it in 16 quarters. The position peaked at $395K in Q4 2017. 1,317 funds tracked by Wall St. Rank hold CELG as of Q4 2018.

  • Northstar Group reported no remaining Celgene Corp position as of Q4 2018 after selling out during the quarter.
  • Northstar Group sold 3,658 Celgene Corp shares in Q4 2018, an estimated $327K.
  • Northstar Group first reported a position in Celgene Corp in Q4 2014 and held it in 16 quarters.
  • Northstar Group's Celgene Corp position peaked at $395K in Q4 2017.
  • 1,317 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2018.

Based on Northstar Group's 13F filing for Q4 2018, filed 22 Jan 2019.